It may have both an anti-spirochaete activity and an anti-inflammatory activity, similar to the treatment of rheumatoid arthritis. And caution is required if patients have certain heart conditions, diabetes, psoriasis etc. Plaquenil with valcyte Para ke sirve plaquenil terapy Plaquenil and atenolol safe together The molecular weight of hydroxychloroquine sulfate is 433.95, and molecular formula is C 18 H 26 ClN 3 O. H 2 SO 4. Hydroxychloroquine sulfate tablets, USP contain 200 mg hydroxychloroquine sulfate, USP equivalent to 155 mg base, and are for oral administration. INDICATIONS AND CLINICAL USE. PLAQUENIL hydroxychloroquine sulfate is indicated for the treatment of rheumatoid arthritis, and discoid and systemic lupus erythematosus, in patients who have not responded satisfactorily to drugs with less potential for serious side effects. Hydroxychloroquine is usually taken with food or milk to prevent stomach upset. The dosage and length of treatment are based on your medical condition and response to therapy. In children, dosage is also based on weight. The most serious adverse effects affect the eye, with dose-related retinopathy as a concern even after hydroxychloroquine use is discontinued. The most common adverse effects are a mild nausea and occasional stomach cramps with mild diarrhea. Is hydroxychloroquine teratogenicity PLAQUENIL® HYDROXYCHLOROQUINE SULFATE TABLETS, USP, Plaquenil Hydroxychloroquine Sulfate Cost of plaquenil in canadaSudden withdrawal of hydroxychloroquine Hydroxychloroquine Plaquenil is a drug that is classified as an anti-malarial drug. Plaquenil is prescribed for the treatment or prevention of malaria. It is also prescribed for the treatment of rheumatoid arthritis, lupus, and the side effects of lupus such as hair loss, joint pain, and more. Hydroxychloroquine Plaquenil Side Effects & Dosage for Malaria. Hydroxychloroquine Oral Uses, Side Effects, Interactions.. Hydroxychloroquine 'Probably Safe' in Pregnancy MDedge ObGyn. Hydroxychloroquine sulphate 747-36-4 Not listed Not listed Not listed Not listed Not listed Mutagenic Effects No information available Reproductive Effects No information available. Developmental Effects No information available. Teratogenicity No information available. STOT - single exposure Respiratory system STOT - repeated exposure None known Hydroxychloroquine, like chloroquine, is a weak base and may exert its effect by concentrating in the acid vesicles of the parasite and by inhibiting polymerization of heme. It can also inhibit certain enzymes by its interaction with DNA. Hydroxychloroquine is in the antimalarial and 4-aminoquinoline families of medication. Hydroxychloroquine was approved for medical use in the United States in 1955. It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.